ES2128145T3 - Derivados de cromano. - Google Patents
Derivados de cromano.Info
- Publication number
- ES2128145T3 ES2128145T3 ES96307772T ES96307772T ES2128145T3 ES 2128145 T3 ES2128145 T3 ES 2128145T3 ES 96307772 T ES96307772 T ES 96307772T ES 96307772 T ES96307772 T ES 96307772T ES 2128145 T3 ES2128145 T3 ES 2128145T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- alkyl
- hydrogen
- chroman derivatives
- bicycloalkylmethyll
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
COMPUESTOS DE FORMULA I SON AGONISTAS SELECTIVOS AUTORECEPTORES UTILES EN EL TRATAMIENTO DE ESTADOS PATOLOGICOS QUE INCLUYEN HIPERACTIVIDAD DE SISTEMAS DE DOPAMINA: EN LA CUAL X ES -(()CH{SUB,2}()){SUB,N}-; N ES 1-3; R{SUB,1} ES HIDROGENO, ALQUILO, HIDROXIALQUILO, CICLOALQUIL-METILO, BICICLOALQUILMETILO O -(()CH{SUB,2}()){SUB,M}YAR; DONDE M ES 04, Y ES CH{SUB,2}-, Y AR ES FENILO, HALOFENILO, ALQUILFENILO, DIALQUILFENILO O ALCOXIFENILO; R{SUB,2} ES HIDROGENO O ALQUILO; R{SUB,3} ES HIDROGENO, HALOGENO, ALQUILO, ALCOXI O HIDROXI; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US730795P | 1995-11-06 | 1995-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2128145T3 true ES2128145T3 (es) | 1999-05-01 |
Family
ID=21725405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96307772T Expired - Lifetime ES2128145T3 (es) | 1995-11-06 | 1996-10-28 | Derivados de cromano. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0771801B1 (es) |
| JP (1) | JPH09169764A (es) |
| KR (1) | KR970027086A (es) |
| CN (1) | CN1083843C (es) |
| AR (1) | AR004523A1 (es) |
| AT (1) | ATE177102T1 (es) |
| AU (1) | AU701636B2 (es) |
| BR (1) | BR9605437B1 (es) |
| CA (1) | CA2189525C (es) |
| CZ (1) | CZ286649B6 (es) |
| DE (1) | DE69601611T2 (es) |
| DK (1) | DK0771801T3 (es) |
| ES (1) | ES2128145T3 (es) |
| GR (1) | GR3030132T3 (es) |
| HU (1) | HUP9603058A3 (es) |
| IL (1) | IL119483A (es) |
| MX (1) | MX9605369A (es) |
| NO (1) | NO964684L (es) |
| NZ (1) | NZ299680A (es) |
| SK (1) | SK281085B6 (es) |
| TW (1) | TW467914B (es) |
| ZA (1) | ZA969191B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT923576E (pt) * | 1996-08-27 | 2003-02-28 | Wyeth Corp | Derivados de 4-amino-etoxi-indolona como agonistas de dopamina d2 |
| ES2196312T3 (es) * | 1996-10-15 | 2003-12-16 | Wyeth Corp | Derivados azaheterociclimetilo de 3,3,9 -tetrahidro-7h 1,4-dioxino (2,3-4) indol-8-0na. |
| EP0964853A1 (en) * | 1997-02-18 | 1999-12-22 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
| US5990144A (en) * | 1997-02-18 | 1999-11-23 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists |
| US6541501B2 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| US6541502B1 (en) | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| TW200811182A (en) | 2006-05-25 | 2008-03-01 | Wyeth Corp | Oxindoledioxans, synthesis thereof, and intermediates thereto |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314944A (en) | 1980-08-22 | 1982-02-09 | Smithkline Corporation | 4-Aminoalkyl-7-hydroxy-2(3H)-indolones |
| DE4135474A1 (de) | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
| DE4140540A1 (de) | 1991-12-09 | 1993-06-17 | Bayer Ag | Neue azaheterocyclylmethyl-chromane |
| SI0707007T1 (en) * | 1994-10-14 | 2002-04-30 | Merck Patent Gmbh | (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent |
-
1996
- 1996-10-24 AR ARP960104889A patent/AR004523A1/es unknown
- 1996-10-24 IL IL11948396A patent/IL119483A/xx not_active IP Right Cessation
- 1996-10-28 ES ES96307772T patent/ES2128145T3/es not_active Expired - Lifetime
- 1996-10-28 EP EP96307772A patent/EP0771801B1/en not_active Expired - Lifetime
- 1996-10-28 DK DK96307772T patent/DK0771801T3/da active
- 1996-10-28 DE DE69601611T patent/DE69601611T2/de not_active Expired - Lifetime
- 1996-10-28 AT AT96307772T patent/ATE177102T1/de not_active IP Right Cessation
- 1996-10-31 SK SK1413-96A patent/SK281085B6/sk unknown
- 1996-10-31 ZA ZA9609191A patent/ZA969191B/xx unknown
- 1996-11-01 AU AU70554/96A patent/AU701636B2/en not_active Ceased
- 1996-11-01 NZ NZ299680A patent/NZ299680A/en unknown
- 1996-11-04 CA CA002189525A patent/CA2189525C/en not_active Expired - Fee Related
- 1996-11-05 HU HU9603058A patent/HUP9603058A3/hu unknown
- 1996-11-05 TW TW085113502A patent/TW467914B/zh active
- 1996-11-05 KR KR1019960052068A patent/KR970027086A/ko not_active Ceased
- 1996-11-05 JP JP8292477A patent/JPH09169764A/ja active Pending
- 1996-11-05 CN CN96114428A patent/CN1083843C/zh not_active Expired - Fee Related
- 1996-11-05 MX MX9605369A patent/MX9605369A/es not_active IP Right Cessation
- 1996-11-05 CZ CZ19963240A patent/CZ286649B6/cs not_active IP Right Cessation
- 1996-11-05 NO NO964684A patent/NO964684L/no not_active Application Discontinuation
- 1996-11-06 BR BRPI9605437-9A patent/BR9605437B1/pt not_active IP Right Cessation
-
1999
- 1999-04-30 GR GR990401214T patent/GR3030132T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9603058D0 (en) | 1996-12-30 |
| AU701636B2 (en) | 1999-02-04 |
| AR004523A1 (es) | 1998-12-16 |
| DE69601611T2 (de) | 1999-10-21 |
| HK1010104A1 (en) | 1999-06-11 |
| CA2189525A1 (en) | 1997-05-07 |
| HUP9603058A2 (en) | 1997-05-28 |
| AU7055496A (en) | 1997-05-15 |
| JPH09169764A (ja) | 1997-06-30 |
| EP0771801A1 (en) | 1997-05-07 |
| GR3030132T3 (en) | 1999-07-30 |
| DE69601611D1 (de) | 1999-04-08 |
| CN1151989A (zh) | 1997-06-18 |
| ZA969191B (en) | 1998-04-30 |
| TW467914B (en) | 2001-12-11 |
| IL119483A0 (en) | 1997-01-10 |
| NZ299680A (en) | 1998-05-27 |
| MX9605369A (es) | 1997-05-31 |
| DK0771801T3 (da) | 1999-09-27 |
| NO964684D0 (no) | 1996-11-05 |
| EP0771801B1 (en) | 1999-03-03 |
| CZ286649B6 (cs) | 2000-05-17 |
| CA2189525C (en) | 2006-04-25 |
| ATE177102T1 (de) | 1999-03-15 |
| BR9605437B1 (pt) | 2009-08-11 |
| HUP9603058A3 (en) | 1998-12-28 |
| CZ324096A3 (en) | 1997-12-17 |
| IL119483A (en) | 1999-06-20 |
| SK281085B6 (sk) | 2000-11-07 |
| BR9605437A (pt) | 1998-08-04 |
| SK141396A3 (en) | 1997-05-07 |
| CN1083843C (zh) | 2002-05-01 |
| NO964684L (no) | 1997-05-07 |
| KR970027086A (ko) | 1997-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2175336T3 (es) | Derivados de triazol utiles en terapia. | |
| HRP20041084B1 (hr) | C-aril glukozid inhibitori sglt2 i postupak | |
| DK0749424T3 (da) | Naphthalenderivater som prostaglandin-I2-agonister | |
| LU91908I2 (fr) | Telavancine, ou un de ses sels pharmaceutiquement acceptable, y compris l'hydrochlorure de telavancine (VIBATIV®) | |
| AR001674A1 (es) | Método para inhibir la obstrucción de conductos por hidrato de gas | |
| CY1105399T1 (el) | Μεθοδος επιλεκτικης υποκαταστασεως των ταξανων | |
| NO20015477D0 (no) | 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler | |
| ATE185341T1 (de) | 4,9-ethano-benzo(f)isoindolderivate als farnesyl transferase inhibitoren | |
| ES2121603T3 (es) | Derivados de 10,11-metanodibenzosuberano usados como agentes quimiosensibilizantes. | |
| NO980467D0 (no) | 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer | |
| NO943762D0 (no) | Indolderivater som 5-HT 1 agonister | |
| TR199701654T1 (xx) | 4-Fenilaminotiyazol t�revleri. | |
| NZ509244A (en) | Treatment regimen for administration of phenylacetylglutamine phenylacetylisoglutamine, and/or phenylacetate | |
| ES2128145T3 (es) | Derivados de cromano. | |
| CY1106402T1 (el) | Μεθοδος θepαπειας του συνδρομου tourette | |
| NO990164D0 (no) | Illudinanaloger nyttige som antitumormidler | |
| TR200001452T2 (tr) | Bifenilamidin türevleri. | |
| RU94045280A (ru) | Средство для ингибирования патологических состояний молочных желез | |
| DK0533790T3 (da) | Hidtil ukendt saltform af 5-difluormethoxy-2-((3,4-dimethoxy-2-pyridyl)methylsulfinyl)-1H-benzimidazol | |
| ES2135342A1 (es) | Procedimiento para prevenir el cancer de mama. | |
| CO4840512A1 (es) | Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos. | |
| ES2174113T3 (es) | Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales. | |
| RU95107655A (ru) | Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция | |
| EP1073447A4 (en) | N1-MODIFIED GLYCOPEPTIDES | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 771801 Country of ref document: ES |